Niklas Prager proposed as the new Chairman of the Board of

The Nomination Committee of BioPhausia AB proposes Niklas Prager as the new
Chairman of the board, to be elected at the Annual General Meeting on 11 May
2010. He is to replace the former Chairman of the board, Jan Rynning, who
decided not to stand for re-election.

"I am looking forward to being part of the future development of BioPhausia,
which is an exciting company in an industry with good future opportunities,"
says Niklas Prager.

It is proposed that the new number of Board members be five. As well as the
Chairman of the board, Jan Rynning, Birgitta Landin, Pia Rudengren and Bengt
Gerdin have said that they will not stand for re-election.

The Nomination Committee proposes that Mats Lindquist, Roger Johanson and Johan
Unger are re-elected and that Niklas Prager and Anna Malm Bernsten be elected as
new members.

Niklas Prager is currently the CEO of Qbtech AB and used to be the CEO of Pfizer
Sverige. Niklas is on the Board of Envirotainer AB.

Anna Malm Bernsten is currently running her own consultancy business in
management and business development and used to be the Chief Marketing Officer
for GE Healthcare Life Sciences. Anna Malm Bernsten is on the Boards of
Artimplant AB, Fagerhult AB and Medivir AB.

The Nomination Committee propose that the fees for the Board of Directors and
the Chairman of the Board be a total of SEK 1,250,000; of which each member will
receive SEK 150,000 kronor, the Chairman of the Board SEK 400,000, and SEK
250,000 for the work of the committee.  Board members will be entitled to
invoice for their directors' fees, as long as the tax conditions are right for
invoicing. If Board members invoice their directors' fees through a company,
this fee has to be increased by a sum that corresponds to the social security
contributions payable by law. VAT also has to be paid by law. It is proposed
that the auditors' fees be paid on approved account.

The Nomination Committee's statement of motivation for its proposals for the
Board of Directors can be found on the company's website, www.biophausia.se
<http://www.biophausia.se/>.

The Nomination Committee which has chosen the Board of Directors for the 2010
general meeting comprises Caroline af Ugglas (Skandia Liv), Jan Rynning
(Chairman of the Board), Sören Berggren (single shareholder) and Tedde Jeansson
(single shareholder). The Nomination Committee represents around 16 % of the
number of shares and votes in BioPhausia AB.

                               Stockholm 21 April
                                     Board
                              BioPhausia AB (publ)

For more information, contact:
Caroline af Ugglas, Chairman of the Board of the Nomination Committee
08-788 10 00
Jan Rynning, Chairman of the Board 0703-51 00 05

The information has been made public according to the securities market act and
the financial instruments trading act.



[HUG#1406997]
Niklas Prager proposed as the new Chairman of the Board of BioPhausia AB (publ)

Attachments
